Follow up of Autoantibodies in Active Tuberculosis

Tel Aviv Sourasky Medical Center

Status: Unknown

Conditions: Tuberculosis

Study type: Observational

Funder types: Other

Identifiers

NCT00551226

314-07

Details and patient eligibility

About

We have previoulsy shown that patients with active Tuberculosis develop a wide array of autoantibodies including rheumatoid factor, anti-CCP, Antinuclear facyor and anti Sm antibodies. The purpose of this study is to evaluate whether the level of autoantibodies decrease after treatment aganist tuberculosis.

Enrollment: 50 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Active Tuberculosis treated

Exclusion criteria

• None

Trial design

50 participants in 2 patient groups

1

Description:

Patients with tuberculosis

2

Description:

Healthy controls